Clinical Trial Update: A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 study of JNJ-80038114 in participants with advanced-stage prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• JNJ-80038114

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED